Advisory Services Network’s Cardiol Therapeutics CRDL Stock Holding History

Advisory Services Network’s Portfolio CRDL Stock Details CRDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.6K	Hold	10,000	–	–	﹤0.01%	2133
2026 Q1	$13.5K	Buy	+10,000	New	+$10.3K	﹤0.01%	3401
2024 Q1	–	Sell	-3,458	Closed	-$2.92K	–	1894
2023 Q4	$2.92K	Buy	+3,458	New	+$2.94K	﹤0.01%	3283
2023 Q2	–	Sell	-3,458	Closed	-$1.69K	–	1895
2023 Q1	$1.69K	Hold	3,458	–	–	﹤0.01%	3479
2022 Q4	$1.76K	Buy	+3,458	New	+$2.11K	﹤0.01%	3480

Other funds holding CRDL

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Integrity Alliance Urbandale, Iowa $3.2B AUM 23.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Advisory Services Network's CRDL Position: Q2 2026 in Review

Advisory Services Network held its Cardiol Therapeutics (CRDL) position steady in Q2 2026 at 10,000 shares worth $10.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2133.

Advisory Services Network first reported a position in CRDL in Q4 2022 and has held it in 5 quarters since. The position peaked at $13.5K in Q1 2026. 52 funds tracked by Wall St. Rank hold CRDL as of Q2 2026.

Advisory Services Network held 10,000 shares of Cardiol Therapeutics worth $10.6K as of Q2 2026.
Advisory Services Network left its Cardiol Therapeutics share count unchanged in Q2 2026.
Cardiol Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q2 2026, its #2133 holding.
Advisory Services Network first reported a position in Cardiol Therapeutics in Q4 2022 and has held it in 5 quarters since.
Advisory Services Network's Cardiol Therapeutics position peaked at $13.5K in Q1 2026.
52 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.